In a recent study published in the Proceedings of the National Academy of Sciences, researchers explored the shortcomings in mucosal immunoglobulin A (IgA) responses induced by existing vaccines ...

Panel A shows mutations in the SARS-CoV-2 spike protein in omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4–BA.5, and BA.4.6. BA.4 and BA.5 are grouped together because they have identical spike ...

In a recent study posted to the bioRxiv* preprint server, researchers described four novel monoclonal antibodies with potent and broad neutralization activity against severe acute respiratory syndrome ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, hinting at a functional cure.

(A) Cryo-EM structure overview of HSV-1 gB in complex with D48 Fab. The side view and top view were presented. The HSV-1 gB trimer and D48 Fab VH/VL were colored differently. (B) Neutralization assay ...

An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly ...

When some viruses infect our bodies, “our immune system can create a type of ‘permanent immunity’, meaning that once you’ve been exposed to that virus, you’ve got protection from it and are typically ...

SARS-CoV-2 has evolved to acquire mutations in the spike protein - the part of the virus that protrudes from its surface and latches onto cells to infect them - that enhance the virus' ability to ...

SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports the ...

Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as ...